Ahmed Nabeel's Form 4 filing
Outset Medical, Inc. (OM) · filed Feb 16, 2023
- Accession no.
- 0001484612-23-000024
- Filed
- Feb 16, 2023
- Trade date
- Feb 16, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $38.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ahmed NabeelCIK 0001870610 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 | Common Stock | SSaleDisposed | −269 | $24.37 | −$6,555.53 | 96,640 | Direct | |
| Feb 16, 2023 | Common Stock | SSaleDisposed | −1,167 | $24.36 | −$28,428.12 | 95,473 | Direct | |
| Feb 16, 2023 | Common Stock | SSaleDisposed | −123 | $24.36 | −$2,996.28 | 95,350 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.